US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.480
  • +0.035+2.42%
Close Nov 22 16:00 ET
  • 1.461
  • -0.019-1.28%
Post 16:11 ET
10.24MMarket Cap-1034P/E (TTM)

Biorestorative Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
660.91%233.6K
38.14%89.1K
11.82%35K
21.70%145.8K
421.62%19.3K
5.86%30.7K
-9.28%64.5K
95.63%31.3K
160.43%119.8K
-26.00%3.7K
Operating revenue
660.91%233.6K
38.14%89.1K
11.82%35K
21.70%145.8K
421.62%19.3K
5.86%30.7K
-9.28%64.5K
95.63%31.3K
160.43%119.8K
-26.00%3.7K
Cost of revenue
18.24K
6.49K
0
0
Gross profit
601.49%215.36K
28.08%82.61K
30.7K
64.5K
Operating expense
-18.00%2.5M
-19.79%2.55M
-28.68%4.14M
-19.49%15.28M
-29.44%3.24M
-34.21%3.05M
-32.31%3.18M
14.99%5.81M
-27.97%18.98M
14.39%4.59M
Selling and administrative expenses
-49.15%1.18M
-44.73%1.26M
-32.60%3.09M
-27.27%11.33M
-46.41%2.15M
-36.28%2.33M
-37.15%2.28M
6.62%4.58M
-39.20%15.58M
4.24%4.01M
-General and administrative expense
-49.15%1.18M
-44.73%1.26M
-32.60%3.09M
-27.27%11.33M
-46.41%2.15M
-36.28%2.33M
-37.15%2.28M
6.62%4.58M
-39.20%15.58M
4.24%4.01M
Research and development costs
63.00%1.32M
43.12%1.29M
-14.09%1.06M
14.84%4.03M
61.83%1.09M
-18.13%809.82K
-16.03%902.89K
58.87%1.23M
381.90%3.51M
307.03%673.62K
Other operating expenses
----
----
----
24.60%-83.33K
--0
---83.33K
----
----
---110.52K
---93.86K
Operating profit
24.30%-2.29M
20.78%-2.47M
28.89%-4.11M
19.75%-15.14M
29.80%-3.22M
34.46%-3.02M
32.67%-3.12M
-14.73%-5.78M
28.30%-18.86M
-14.44%-4.59M
Net non-operating interest income expense
157.10%158.55K
82.92%175.95K
792.61%162.6K
4,640.71%552.29K
224.01%376.22K
313.82%61.67K
306.35%96.19K
162.79%18.22K
100.64%11.65K
154.31%116.12K
Non-operating interest income
157.10%158.55K
82.92%175.95K
792.61%162.6K
4,640.71%552.29K
--376.22K
--61.67K
--96.19K
--18.22K
--11.65K
----
Other net income (expense)
-86.58%1.04M
35.45%-1.74M
222.08%1.72M
-25.97%4.17M
-89.99%540.47K
44,810.16%7.73M
-2.69M
-664.68%-1.41M
134.79%5.63M
5.4M
Gain on sale of security
-86.53%1.04M
----
--1.71M
----
----
--7.69M
----
----
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
--250K
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
---250K
--0
Other non- operating income (expenses)
-98.33%566
35.45%-1.74M
100.83%11.7K
-22.53%4.17M
-25.57%4.02M
296.43%33.95K
---2.69M
---1.41M
133.25%5.38M
--5.4M
Income before tax
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
-349.10%-2.3M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
Income tax
Net income
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
-349.10%-2.3M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
Net income continuous Operations
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
-349.10%-2.3M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
Minority interest income
Net income attributable to the parent company
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
-349.10%-2.3M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
21.21%-10.42M
-349.10%-2.3M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
Basic earnings per share
-112.50%-0.13
65.99%-0.5
82.90%-0.33
32.33%-2.47
-267.86%-0.47
181.25%1.04
-14.84%-1.47
-40.88%-1.93
90.21%-3.65
104.83%0.28
Diluted earnings per share
-133.33%-0.13
65.99%-0.5
82.90%-0.33
32.33%-2.47
-267.86%-0.47
130.47%0.39
-14.84%-1.47
-40.88%-1.93
90.21%-3.65
104.83%0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 660.91%233.6K38.14%89.1K11.82%35K21.70%145.8K421.62%19.3K5.86%30.7K-9.28%64.5K95.63%31.3K160.43%119.8K-26.00%3.7K
Operating revenue 660.91%233.6K38.14%89.1K11.82%35K21.70%145.8K421.62%19.3K5.86%30.7K-9.28%64.5K95.63%31.3K160.43%119.8K-26.00%3.7K
Cost of revenue 18.24K6.49K00
Gross profit 601.49%215.36K28.08%82.61K30.7K64.5K
Operating expense -18.00%2.5M-19.79%2.55M-28.68%4.14M-19.49%15.28M-29.44%3.24M-34.21%3.05M-32.31%3.18M14.99%5.81M-27.97%18.98M14.39%4.59M
Selling and administrative expenses -49.15%1.18M-44.73%1.26M-32.60%3.09M-27.27%11.33M-46.41%2.15M-36.28%2.33M-37.15%2.28M6.62%4.58M-39.20%15.58M4.24%4.01M
-General and administrative expense -49.15%1.18M-44.73%1.26M-32.60%3.09M-27.27%11.33M-46.41%2.15M-36.28%2.33M-37.15%2.28M6.62%4.58M-39.20%15.58M4.24%4.01M
Research and development costs 63.00%1.32M43.12%1.29M-14.09%1.06M14.84%4.03M61.83%1.09M-18.13%809.82K-16.03%902.89K58.87%1.23M381.90%3.51M307.03%673.62K
Other operating expenses ------------24.60%-83.33K--0---83.33K-----------110.52K---93.86K
Operating profit 24.30%-2.29M20.78%-2.47M28.89%-4.11M19.75%-15.14M29.80%-3.22M34.46%-3.02M32.67%-3.12M-14.73%-5.78M28.30%-18.86M-14.44%-4.59M
Net non-operating interest income expense 157.10%158.55K82.92%175.95K792.61%162.6K4,640.71%552.29K224.01%376.22K313.82%61.67K306.35%96.19K162.79%18.22K100.64%11.65K154.31%116.12K
Non-operating interest income 157.10%158.55K82.92%175.95K792.61%162.6K4,640.71%552.29K--376.22K--61.67K--96.19K--18.22K--11.65K----
Other net income (expense) -86.58%1.04M35.45%-1.74M222.08%1.72M-25.97%4.17M-89.99%540.47K44,810.16%7.73M-2.69M-664.68%-1.41M134.79%5.63M5.4M
Gain on sale of security -86.53%1.04M------1.71M----------7.69M----------------
Special income (charges) --------------0------------------250K--0
-Less:Other special charges -----------------------------------250K--0
Other non- operating income (expenses) -98.33%56635.45%-1.74M100.83%11.7K-22.53%4.17M-25.57%4.02M296.43%33.95K---2.69M---1.41M133.25%5.38M--5.4M
Income before tax -122.89%-1.09M29.44%-4.03M69.00%-2.22M21.21%-10.42M-349.10%-2.3M202.41%4.77M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K
Income tax
Net income -122.89%-1.09M29.44%-4.03M69.00%-2.22M21.21%-10.42M-349.10%-2.3M202.41%4.77M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K
Net income continuous Operations -122.89%-1.09M29.44%-4.03M69.00%-2.22M21.21%-10.42M-349.10%-2.3M202.41%4.77M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K
Minority interest income
Net income attributable to the parent company -122.89%-1.09M29.44%-4.03M69.00%-2.22M21.21%-10.42M-349.10%-2.3M202.41%4.77M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -122.89%-1.09M29.44%-4.03M69.00%-2.22M21.21%-10.42M-349.10%-2.3M202.41%4.77M-22.12%-5.71M-48.93%-7.17M70.16%-13.22M104.53%924.92K
Basic earnings per share -112.50%-0.1365.99%-0.582.90%-0.3332.33%-2.47-267.86%-0.47181.25%1.04-14.84%-1.47-40.88%-1.9390.21%-3.65104.83%0.28
Diluted earnings per share -133.33%-0.1365.99%-0.582.90%-0.3332.33%-2.47-267.86%-0.47130.47%0.39-14.84%-1.47-40.88%-1.9390.21%-3.65104.83%0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data